The addressed topics will be:
• thyroid: replacement treatment for hypothyroidism. Use of thyroid kinase inhibitors for advanced thyroid cancer.
• hypoparathyroidism: how to manage a neglected disease in 2025.
• obesity: the landscape of new drugs, the tailored management for the individual patient and perspectives on monogenic obesities.
• endogenous hypercortisolism: an update on clinical management.
• bone metabolism: advanced treatment for osteoporosis and the clinical management of their side effects.
• vitamin d deficiency: lights and shadows about guidelines
• adrenogenital syndromes: the unmet needs.
• neuroendocrine tumors: is there still a role for somatostatin receptor ligands?